Old Republic International Corporation, through its subsidiaries, provides insurance underwriting and related services primarily in the United States and Canada. The company operates in two segments, Specialty Insurance and Title Insurance. The Specialty Insurance segment offers accident and health, aviation, commercial auto, commercial multi-peril, commercial property, excess and surplus, general liability, home and auto warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, directors and officers, and surety. This segment provides its insurance products to businesses, state and local governments, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. Old Republic International Corporation was founded in 1923 and is based in Chicago, Illinois.

Old Republic International Corporation

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, gained 0.43% in pre-ma...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/8/2026

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.03% in pre-mark...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/7/2026

JonesTrading analyst Soumit Roy maintained a Buy rating on Oric Pharmaceuticals today and set a price target of $25.00. Roy covers the Healthcare s...

JonesTrading Sticks to Their Buy Rating for Oric Pharmaceuticals (ORIC)

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, closed 0.16% higher on...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/3/2026

Which stocks are best to buy now amid the recent market pullback? According to Top Wall Street Analysts, the three stocks listed below are Strong B...

3 Best Stocks to Buy amid the Market Pullback, According to Top Analysts

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.23% in pre-mark...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/2/2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pha...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC)

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.20% in pre-mark...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/1/2026

An announcement from Oric Pharmaceuticals ( ($ORIC) ) is now available. On March 31, 2026, ORIC Pharmaceuticals presented an update on dose optimiz...

Oric Advances Rinzimetostat Toward First Prostate Cancer Phase 3

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited has reduced its issued capital through the cancellation of 1,344,290 ordin...

Orica Cancels 1.34 Million Shares in On-Market Buy-Back

Orica Limited ( ($AU:ORI) ) has shared an announcement. Orica Limited has provided an updated notification to the ASX regarding its ongoing on‑mark...

Orica Updates Market on Progress of On‑Market Share Buy-Back

Orica Limited ( ($AU:ORI) ) just unveiled an announcement. Norges Bank has notified Orica Limited that it has ceased to be a substantial shareholde...

Norges Bank Exits Substantial Holder Position in Orica

Orica Limited ( ($AU:ORI) ) just unveiled an update. AustralianSuper Pty Ltd has notified Orica Ltd that it has ceased to be a substantial sharehol...

AustralianSuper exits substantial holder status in Orica after major share selldown

HSBC analyst Parash Jain maintained a Hold rating on Orient Overseas (International) on March 14 and set a price target of HK$130.00. Jain covers t...

Orient Overseas (International) (OROVF) Gets a Hold from HSBC

In a report released today, Belinda Moore from Morgans maintained a Buy rating on Orica Limited, with a price target of A$25.35. According to TipRa...

Morgans Sticks to Their Buy Rating for Orica Limited (OCLDF)

In a report released today, from Ord Minnett maintained a Buy rating on Orica Limited, with a price target of A$25.00. In addition to Ord Minnett, ...

Orica Limited (OCLDF) Gets a Buy from Ord Minnett

In a report released today, from Macquarie maintained a Buy rating on Orica Limited, with a price target of A$25.40. In addition to Macquarie, Oric...

Macquarie Sticks to Its Buy Rating for Orica Limited (OCLDF)

In a report released on March 10, Jakob Cakarnis from Jarden maintained a Buy rating on Orica Limited, with a price target of A$24.60. The company’...

Jarden Remains a Buy on Orica Limited (OCLDF)

Orient Overseas (International) ( ($HK:0316) ) has issued an announcement. Orient Overseas (International) Limited has proposed a final ordinary di...

Orient Overseas Proposes Final 2025 Dividend With Multi-Currency Option

An announcement from Orient Overseas (International) ( ($HK:0316) ) is now available. Orient Overseas (International) Limited reported a sharp year...

OOIL Profit Falls as Revenue and Margins Weaken in 2025

Orica Limited ( ($AU:ORI) ) has shared an update. Orica Limited has issued an updated notification to the ASX regarding its ongoing on-market share...

Market Cap	$10.71B	P/E Ratio	12.80
52W High	$46.76	52W Low	$34.43
Div Yield	126.0%	Payout Ratio	-180.7%
EPS Growth 3Y	N/A	52W Position	58.1%
Overall Score	71	Value Score	100
Quality Score	42	Technical Score	72

EPS Current Est	$3.25	EPS Next Est	$3.35
EPS Growth Est	+3.1%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ORI	$41.59	+0.60%	1.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ORI	$41.59	+0.6%	1.02M
3
4
5
6

ORI

ORI

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Old Republic International Corporation Data in Excel

Get Old Republic International Corporation Data in Excel